| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 105 |
| 1 | PREDNISOLONE | 40 |
| 2 | PREDNISOLONE ORAL | 40 |
| 3 | PREDNISOLONE ORAL SOLUTION | 40 |
| 4 | CYCLOPHOSPHAMIDE | 38 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 38 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 38 |
| 7 | HUMAN IMMUNOGLOBULIN G | 38 |
| 8 | ERGOCALCIFEROL | 35 |
| 9 | PREDNISONE | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL, PYRILAMINE MALEATE | 1 | 0.1000 |
| 1 | HEPATITIS B IMMUNE GLOBULIN (HUMAN) | 1 | 0.0196 |
| 2 | PHENDIMETRAZINE TARTRATE | 1 | 0.0172 |
| 3 | PRAMLINTIDE ACETATE | 1 | 0.0098 |
| 4 | NITAZOXANIDE | 3 | 0.0086 |
| 5 | FERROUS FUMARATE AND POLYSACCHRIDE IRON VITAMIN MINERAL COMPLEX SUPPLEMENT | 1 | 0.0051 |
| 6 | VINBLASTINE SULFATE | 6 | 0.0031 |
| 7 | UBLITUXIMAB | 10 | 0.0026 |
| 8 | PINDOLOL | 2 | 0.0025 |
| 9 | BARICITINIB | 7 | 0.0023 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 120 |
| 1 | Corticosteroid [EPC] | 117 |
| 2 | Human Immunoglobulin G [EPC] | 56 |
| 3 | Benzodiazepine [EPC] | 41 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 41 |
| 5 | Alkylating Drug [EPC] | 38 |
| 6 | Provitamin D2 Compound [EPC] | 35 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 31 |
| 8 | Anti-epileptic Agent [EPC] | 27 |
| 9 | Proton Pump Inhibitor [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin [EPC] | 1 | 0.0196 |
| 1 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 2 | Human Immunoglobulin G [EPC] | 56 | 0.0027 |
| 3 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 5 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 6 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 7 | Plasma Kallikrein Inhibitor [EPC] | 3 | 0.0013 |
| 8 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 2 | 0.0012 |
| 9 | Provitamin D2 Compound [EPC] | 35 | 0.0012 |